Skip to content
Clinical Trials – home

Wojewódzki Szpital Specjalistyczny nr 5 im. św. Barbary w Sosnowcu

Verifiedinfo

Poland Pl. Medykow 1, 41-200 Sosnowiec, Poland

  • 3 trials recruiting
  • Crohn's disease · Colitis ulcerative · Systemic scleroderma
  • Adult patients

About Specializations

Wojewódzki Szpital Specjalistyczny nr 5 im. św. Barbary w Sosnowcu in Sosnowiec, Poland specialises in clinical trials of conditions such as Crohn's disease, Colitis ulcerative, Systemic scleroderma, and other specialisations. This site conducts important research.

Main research areas of the site

Neuro-Oncology

The medical center is at the forefront of neuro-oncology, focusing on innovative treatments for Glioblastoma Multiforme (GBM). This aggressive brain tumor presents significant challenges, and the center is dedicated to advancing therapeutic strategies to improve patient outcomes.

  • Neoadjuvant and adjuvant therapies
  • Immunotherapy integration
  • Standard chemo-radiotherapy enhancements

Through ongoing research, the center is exploring the efficacy of combining Pembrolizumab with the established Stupp protocol, aiming to enhance both short-term and long-term patient responses.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Pl. Medykow 141-200 SosnowiecPoland
Recruiting now
3 trials
Conditions studied
3
Partner status
Verified

More sites in SosnowiecPoland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

4 clinical trials

Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Infliximab
  • Sponsor:Agencja Badań Medycznych
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Infliximab
  • Sponsor:Agencja Badań Medycznych
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Agencja Badań Medycznych

Systemic scleroderma

Not recruiting
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Anifrolumab
  • Sponsor:AstraZeneca AB
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.